Serono | Evaluate

October 20, 2015

Interview – Karolinska focuses, but not on early-stage medtech

Huge second quarter for M&A sets 2014 on track for record year

June 19, 2014

For oncology deals, don’t forget the other Merck

April 10, 2014

Myriad moves to turn homebrew into companion diagnostic, but path is risky

July 15, 2013

EP Vantage interview – Auxogyn’s viability boosted by embryo selection tool

November 22, 2012

EP Vantage Interview – Poxel treading novel path to diabetes success

September 19, 2012

Pharma’s hatchet men ask, are you local?

September 06, 2012

Symphogen reaps second Sym004 harvest with Merck Serono deal

May 14, 2012

EP Vantage Interview - F-Star to push forward with bispecific antibody pipeline

November 04, 2011

Ablynx and ImmuPharma dealing with big pharma rejection

April 20, 2011

Vantage Point - Corporate VCs put into perspective

Load More